Showing 3781-3790 of 4063 results for "".
- Novartis Responds to ASRS Note Raising Safety Concerns With Wet AMD Drug Beovuhttps://modernod.com/news/novartis-responds-to-asrs-note-raising-safety-concerns-of-beovu/2477325/Novartis confirmed to Eyewire News that it is launching an internal and external review of new information that raises serious safety concerns over its wet age-related macular degeneration (AMD) drug Beovu (brolucizumab). On February 23, the American Society of Retinal Specialists (ASRS) s
- ReNeuron Announces Positive Long-Term Data in Retinitis Pigmentosa Trialhttps://modernod.com/news/reneuron-announces-positive-long-term-data-in-retinitis-pigmentosa-trial/2477320/ReNeuron Group has announced positive long-term data from the ongoing phase 1/2a clinical trial of its hRPC stem cell therapy candidate in retinitis pigmentosa (RP) and plans to expand the ongoing study. In October 2019, positive interim efficacy data from p
- AbbVie-Allergan Deal Foes Try Again to Spur an FTC Crackdownhttps://modernod.com/news/abbvie-allergan-deal-foes-try-again-to-spur-an-ftc-crackdown/2477311/AbbVie and Allergan’s megamerger is likely in the final stages of review after the pair agreed to offload three drugs, including IL-23 hopeful brazikumab. But a cadre of union and consumer groups say that’s not enough—and they’re taking another stab at turning regulators against
- Certain Chronic Illnesses Tied to Increased Crash Risk for Elderly Drivershttps://modernod.com/news/certain-chronic-illnesses-tied-to-increased-crash-risk-for-elderly-drivers/2477296/Some older drivers with chronic health problems may cut back on driving but still be at increased risk of crashes, a recent study suggests, as reported by Reuters. Meanwhile, other drivers with medical issues may also be at higher
- Verana Health Acquires PYA Analytics; Announces $100 Million Financinghttps://modernod.com/news/verana-health-acquires-pya-analytics-announces-100-million-financing/2477275/Verana Health announced that it has acquired the assets of data science company PYA Analytics (PYAA). Based in Knoxville, Tennessee, PYAA specializes in large-scale data architecture solutions. Terms of the deal were not disclosed. PYAA was founded in 2013 by scientists and engineer
- ForwardVue Pharma CEO: “Short Path to the Clinic” for Retinal Disease Treatmenthttps://modernod.com/news/forwardvue-pharma-ceo-short-path-to-the-clinic-for-retinal-disease-treatment/2477263/In an interview with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco, ForwardVue Pharmaceuticals CEO Alan Franklin, MD, PhD, who is an ophthalmologist, said the company’s lead molecule aims to treat retinal neovascular disease.
- Optimal Atropine Concentration for Two Year Myopia Control Affirmedhttps://modernod.com/news/optimal-atropine-concentration-for-two-year-myopia-control-affirmed/2477255/Atropine 0.05% remains the optimal concentration for slowing myopia progression among Chinese children, the LAMP study extension shows, according to a Reuters report. In a 2011 study, atropine 0.01% – but not 0.1% or 0.5% 
- Tangible Science Announces Timing for Tangible Boost Launchhttps://modernod.com/news/tangible-science-announces-timing-for-tangible-boost-launch/2477250/Tangible Science recapped its 2019 accomplishments and announced the expected launch timing for its new conditioning solution, Tangible Boost. In 2019, the company developed agreements and collaborated with SynergEyes, Contamac, Bausch+Lomb, Paragon Vision Sciences, and Acuity Polymers to
- MacuLogix Introduces the AdaptDx Pro Guided by Theiahttps://modernod.com/news/maculogix-introduces-the-adaptdx-pro-guided-by-theia/2477230/MacuLogix has introduced the AdaptDx Pro guided by Thei, a next generation dark adaptation functional testing. The company’s original AdaptDx automated dark adaptometer was introduced in 2014 and has since been used by more than 1,000 eye care professionals to identify and monitor AMD. The
- AbbVie Announces Leadership Team and Creation of New Business, Allergan Aesthetics, Upon Completion of Acquisitionhttps://modernod.com/news/abbvie-announces-leadership-team-and-creation-of-new-business-allergan-aesthetics-upon-completion-of-acquisition/2477216/AbbVie announced the creation of a new global business, Allergan Aesthetics, and the proposed leadership team for the combined company, effective upon the expected first-quarter 2020 close of the Allergan acquisition. Allergan Aesthetics will operate as a new global dedicated business wit